Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma

Published:2018-10-11 Issue:8 Volume:19 Page:611-621
ISSN:1389-2010
Container-title:Current Pharmaceutical Biotechnology
language:en
Short-container-title:CPB

Author:

Setten Ryan L.¹,Lightfoot Helen L.²,Habib Nagy A.³,Rossi John J.¹

Affiliation:

1. Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, Duarte, CA, United States

2. MiNA Therapeutics Limited, Translation & Innovation Hub, 80 Wood Lane, London, W12 0BZ, United Kingdom

3. Department of Surgery and Cancer, Imperial College London, London, United Kingdom

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Biotechnology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA-based Therapeutics: Past, Present and Future Prospects, Challenges in Cancer Treatment;Current Pharmaceutical Biotechnology;2024-12

2. Small activating RNA delivery in vivo: Challenges, prospects, and lessons learned from siRNA delivery;Nano Research;2024-08-01

3. Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?;Pharmaceuticals;2024-07-16

4. Nanocarriers: Exploring the Potential of Oligonucleotide Delivery;Current Drug Delivery;2024-06-24

5. Nano-based drug delivery systems in hepatocellular carcinoma;Journal of Drug Targeting;2024-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP